Funding Briefs

Appointment of a new executive director is expected to be announced early this year by the Camille and Henry Dreyfus Foundation of New York, and one of the programs the new director will review and probably tinker with is the grant program in chemistry for liberal arts colleges. This program provides $45,000 for each of 10 schools to pair a recent Ph.D. in chemistry as a teaching fellow with an established chemistry professor as mentor. The foundation staff is considering proposing some improv

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Appointment of a new executive director is expected to be announced early this year by the Camille and Henry Dreyfus Foundation of New York, and one of the programs the new director will review and probably tinker with is the grant program in chemistry for liberal arts colleges. This program provides $45,000 for each of 10 schools to pair a recent Ph.D. in chemistry as a teaching fellow with an established chemistry professor as mentor. The foundation staff is considering proposing some improvements for the program - namely, a more specific application form and multiyear awards instead of the current one-year term.

Meanwhile, until such changes come to pass, institutions applying to the program are advised to pay special attention to documenting their track records, says the Dreyfus staff. In particular, applicants should quantify their ability to encourage students to continue their education in chemistry.

(Wendy van Tassell, Camille and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies